Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chemokine (C-C motif) receptor 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | metabotropic glutamate receptor | 0.0163 | 0.0706 | 0.0516 |
Schistosoma mansoni | glutamate receptor kainate | 0.0137 | 0.0458 | 0.0218 |
Giardia lamblia | Kinesin-5 | 0.0146 | 0.0546 | 0.5 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0231 | 0.1369 | 0.1314 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.018 | 0.0873 | 0.0873 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0281 | 0.1846 | 1 |
Loa Loa (eye worm) | kinesin-like protein KLP2 | 0.0146 | 0.0546 | 0.208 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0118 | 0.0277 | 0.0277 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.018 | 0.0873 | 0.0873 |
Schistosoma mansoni | kinesin eg-5 | 0.0146 | 0.0546 | 0.0324 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.018 | 0.0873 | 0.0873 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0231 | 0.1369 | 0.1369 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0118 | 0.0277 | 0.0277 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0118 | 0.0277 | 0.0277 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0308 | 0.2111 | 0.2207 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0351 | 0.2526 | 0.2526 |
Schistosoma mansoni | hypothetical protein | 0.0979 | 0.8589 | 1 |
Loa Loa (eye worm) | glutamate receptor | 0.0281 | 0.1846 | 0.7282 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0238 | 0.1432 | 0.7723 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.018 | 0.0873 | 0.0873 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.018 | 0.0873 | 0.0873 |
Schistosoma mansoni | glutamate receptor kainate | 0.0137 | 0.0458 | 0.0218 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.018 | 0.0873 | 0.0873 |
Loa Loa (eye worm) | hypothetical protein | 0.0351 | 0.2526 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0113 | 0.0231 | 0.0231 |
Echinococcus granulosus | glutamate receptor 2 | 0.009 | 0.0008 | 0.0008 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0163 | 0.0706 | 0.3732 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0231 | 0.1369 | 0.1369 |
Plasmodium vivax | kinesin-5 | 0.0146 | 0.0546 | 0.5 |
Echinococcus multilocularis | kinesin family 1 | 0.1125 | 1 | 1 |
Echinococcus multilocularis | glutamate receptor 2 | 0.009 | 0.0008 | 0.0008 |
Loa Loa (eye worm) | glutamate receptor | 0.012 | 0.0291 | 0.106 |
Entamoeba histolytica | kinesin, putative | 0.0146 | 0.0546 | 0.5 |
Brugia malayi | Kinesin motor domain containing protein | 0.0146 | 0.0546 | 0.2857 |
Toxoplasma gondii | kinesin motor domain-containing protein | 0.0146 | 0.0546 | 0.5 |
Echinococcus granulosus | glutamate receptor 2 | 0.0118 | 0.0277 | 0.0277 |
Plasmodium falciparum | kinesin-5 | 0.0146 | 0.0546 | 0.5 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0351 | 0.2526 | 0.2526 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 110 nM | Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor. | ChEMBL. | 11206474 |
IC50 (binding) | = 110 nM | Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor. | ChEMBL. | 11206474 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.